AAPL289.16+7.42 (+2.63%) ▲|ABBV252.55-1.76 (-0.69%) ▼|ABT91.62-1.09 (-1.18%) ▼|ACN123.89-0.85 (-0.68%) ▼|ADBE202.40-4.04 (-1.95%) ▼|AMAT730.21+35.57 (+5.12%) ▲|AMD572.95+33.46 (+6.20%) ▲|AMGN359.32-1.23 (-0.34%) ▼|AMT164.00-4.67 (-2.77%) ▼|AMZN239.47-0.67 (-0.28%) ▼|AVGO375.32+2.87 (+0.77%) ▲|AXP337.93-2.95 (-0.87%) ▼|BA216.73+2.04 (+0.95%) ▲|BAC57.02-0.87 (-1.49%) ▼|BKNG179.97-2.44 (-1.34%) ▼|BLK961.93+11.76 (+1.24%) ▲|BMY57.76-0.81 (-1.37%) ▼|BNY144.96+1.16 (+0.81%) ▲|BRK-B496.56+0.56 (+0.11%) ▲|C140.00-2.49 (-1.75%) ▼|CAT1,063.07+29.88 (+2.89%) ▲|CL91.95-0.46 (-0.49%) ▼|CMCSA24.54+0.32 (+1.30%) ▲|COF200.47-1.81 (-0.89%) ▼|COP104.36+0.16 (+0.15%) ▲|COST936.72-9.96 (-1.05%) ▼|CRM154.85-3.08 (-1.95%) ▼|CSCO118.13+0.43 (+0.36%) ▲|CVS103.39-0.20 (-0.19%) ▼|CVX167.77-0.70 (-0.42%) ▼|DE627.71+2.70 (+0.43%) ▲|DHR190.17-2.61 (-1.35%) ▼|DIS96.82-1.07 (-1.09%) ▼|DUK127.75-0.58 (-0.45%) ▼|EMR143.17+0.35 (+0.25%) ▲|FDX310.30-15.10 (-4.64%) ▼|GD352.36+4.29 (+1.23%) ▲|GE372.14-1.57 (-0.42%) ▼|GEV1,136.11+33.60 (+3.05%) ▲|GILD125.94-0.40 (-0.31%) ▼|GM76.24-1.10 (-1.42%) ▼|GOOG353.23+1.95 (+0.56%) ▲|GOOGL356.25+2.60 (+0.74%) ▲|GS1,012.12-8.09 (-0.79%) ▼|HD351.68+0.87 (+0.25%) ▲|HON223.56-4.24 (-1.86%) ▼|IBM277.94-0.06 (-0.02%) ▼|INTC139.67+7.95 (+6.04%) ▲|INTU261.85-4.55 (-1.71%) ▼|ISRG402.03-3.94 (-0.97%) ▼|JNJ255.29-3.23 (-1.25%) ▼|JPM327.51-1.88 (-0.57%) ▼|KO82.02-0.63 (-0.76%) ▼|LIN519.52+8.46 (+1.65%) ▲|LLY1,209.02-20.91 (-1.70%) ▼|LMT505.63+3.56 (+0.71%) ▲|LOW219.21-0.44 (-0.20%) ▼|LRCX426.47+15.56 (+3.79%) ▲|MA511.55+1.91 (+0.37%) ▲|MCD269.20+2.02 (+0.76%) ▲|MDLZ58.98-1.17 (-1.95%) ▼|MDT79.32-1.62 (-2.00%) ▼|META556.23-6.37 (-1.13%) ▼|MMM162.36-0.08 (-0.05%) ▼|MO72.57-1.48 (-2.00%) ▼|MRK128.35-1.03 (-0.80%) ▼|MS209.12-2.60 (-1.23%) ▼|MSFT370.29+1.72 (+0.47%) ▲|MU1,143.41-1.88 (-0.16%) ▼|NEE88.15-0.51 (-0.58%) ▼|NFLX72.68-1.11 (-1.50%) ▼|NKE41.04-0.45 (-1.07%) ▼|NOW97.61-2.37 (-2.37%) ▼|NVDA198.38+3.41 (+1.75%) ▲|ORCL145.41-2.36 (-1.59%) ▼|PEP136.34-2.34 (-1.69%) ▼|PFE24.08-0.29 (-1.19%) ▼|PG145.79-2.67 (-1.80%) ▼|PLTR116.87+1.17 (+1.01%) ▲|PM179.75-3.13 (-1.71%) ▼|QCOM186.61-2.11 (-1.12%) ▼|RTX188.55+1.22 (+0.65%) ▲|SBUX102.88-1.18 (-1.13%) ▼|SCHW92.47+1.92 (+2.12%) ▲|SO96.40-0.36 (-0.37%) ▼|SPG224.92-2.65 (-1.16%) ▼|T20.90-0.93 (-4.24%) ▼|TMO500.05-6.37 (-1.26%) ▼|TMUS168.85-5.12 (-2.94%) ▼|TSLA416.37+4.53 (+1.10%) ▲|TXN294.38+8.90 (+3.12%) ▲|UBER73.38-2.12 (-2.81%) ▼|UNH416.48-3.34 (-0.80%) ▼|UNP271.91-0.80 (-0.29%) ▼|UPS106.37-1.64 (-1.52%) ▼|USB60.54-0.22 (-0.36%) ▼|V342.68+1.03 (+0.30%) ▲|VZ42.78-1.32 (-2.99%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.63-0.98 (-0.85%) ▼|XOM136.10+0.04 (+0.03%) ▲|AAPL289.16+7.42 (+2.63%) ▲|ABBV252.55-1.76 (-0.69%) ▼|ABT91.62-1.09 (-1.18%) ▼|ACN123.89-0.85 (-0.68%) ▼|ADBE202.40-4.04 (-1.95%) ▼|AMAT730.21+35.57 (+5.12%) ▲|AMD572.95+33.46 (+6.20%) ▲|AMGN359.32-1.23 (-0.34%) ▼|AMT164.00-4.67 (-2.77%) ▼|AMZN239.47-0.67 (-0.28%) ▼|AVGO375.32+2.87 (+0.77%) ▲|AXP337.93-2.95 (-0.87%) ▼|BA216.73+2.04 (+0.95%) ▲|BAC57.02-0.87 (-1.49%) ▼|BKNG179.97-2.44 (-1.34%) ▼|BLK961.93+11.76 (+1.24%) ▲|BMY57.76-0.81 (-1.37%) ▼|BNY144.96+1.16 (+0.81%) ▲|BRK-B496.56+0.56 (+0.11%) ▲|C140.00-2.49 (-1.75%) ▼|CAT1,063.07+29.88 (+2.89%) ▲|CL91.95-0.46 (-0.49%) ▼|CMCSA24.54+0.32 (+1.30%) ▲|COF200.47-1.81 (-0.89%) ▼|COP104.36+0.16 (+0.15%) ▲|COST936.72-9.96 (-1.05%) ▼|CRM154.85-3.08 (-1.95%) ▼|CSCO118.13+0.43 (+0.36%) ▲|CVS103.39-0.20 (-0.19%) ▼|CVX167.77-0.70 (-0.42%) ▼|DE627.71+2.70 (+0.43%) ▲|DHR190.17-2.61 (-1.35%) ▼|DIS96.82-1.07 (-1.09%) ▼|DUK127.75-0.58 (-0.45%) ▼|EMR143.17+0.35 (+0.25%) ▲|FDX310.30-15.10 (-4.64%) ▼|GD352.36+4.29 (+1.23%) ▲|GE372.14-1.57 (-0.42%) ▼|GEV1,136.11+33.60 (+3.05%) ▲|GILD125.94-0.40 (-0.31%) ▼|GM76.24-1.10 (-1.42%) ▼|GOOG353.23+1.95 (+0.56%) ▲|GOOGL356.25+2.60 (+0.74%) ▲|GS1,012.12-8.09 (-0.79%) ▼|HD351.68+0.87 (+0.25%) ▲|HON223.56-4.24 (-1.86%) ▼|IBM277.94-0.06 (-0.02%) ▼|INTC139.67+7.95 (+6.04%) ▲|INTU261.85-4.55 (-1.71%) ▼|ISRG402.03-3.94 (-0.97%) ▼|JNJ255.29-3.23 (-1.25%) ▼|JPM327.51-1.88 (-0.57%) ▼|KO82.02-0.63 (-0.76%) ▼|LIN519.52+8.46 (+1.65%) ▲|LLY1,209.02-20.91 (-1.70%) ▼|LMT505.63+3.56 (+0.71%) ▲|LOW219.21-0.44 (-0.20%) ▼|LRCX426.47+15.56 (+3.79%) ▲|MA511.55+1.91 (+0.37%) ▲|MCD269.20+2.02 (+0.76%) ▲|MDLZ58.98-1.17 (-1.95%) ▼|MDT79.32-1.62 (-2.00%) ▼|META556.23-6.37 (-1.13%) ▼|MMM162.36-0.08 (-0.05%) ▼|MO72.57-1.48 (-2.00%) ▼|MRK128.35-1.03 (-0.80%) ▼|MS209.12-2.60 (-1.23%) ▼|MSFT370.29+1.72 (+0.47%) ▲|MU1,143.41-1.88 (-0.16%) ▼|NEE88.15-0.51 (-0.58%) ▼|NFLX72.68-1.11 (-1.50%) ▼|NKE41.04-0.45 (-1.07%) ▼|NOW97.61-2.37 (-2.37%) ▼|NVDA198.38+3.41 (+1.75%) ▲|ORCL145.41-2.36 (-1.59%) ▼|PEP136.34-2.34 (-1.69%) ▼|PFE24.08-0.29 (-1.19%) ▼|PG145.79-2.67 (-1.80%) ▼|PLTR116.87+1.17 (+1.01%) ▲|PM179.75-3.13 (-1.71%) ▼|QCOM186.61-2.11 (-1.12%) ▼|RTX188.55+1.22 (+0.65%) ▲|SBUX102.88-1.18 (-1.13%) ▼|SCHW92.47+1.92 (+2.12%) ▲|SO96.40-0.36 (-0.37%) ▼|SPG224.92-2.65 (-1.16%) ▼|T20.90-0.93 (-4.24%) ▼|TMO500.05-6.37 (-1.26%) ▼|TMUS168.85-5.12 (-2.94%) ▼|TSLA416.37+4.53 (+1.10%) ▲|TXN294.38+8.90 (+3.12%) ▲|UBER73.38-2.12 (-2.81%) ▼|UNH416.48-3.34 (-0.80%) ▼|UNP271.91-0.80 (-0.29%) ▼|UPS106.37-1.64 (-1.52%) ▼|USB60.54-0.22 (-0.36%) ▼|V342.68+1.03 (+0.30%) ▲|VZ42.78-1.32 (-2.99%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.63-0.98 (-0.85%) ▼|XOM136.10+0.04 (+0.03%) ▲|
28.8 C
New York
Tuesday, June 30, 2026

Tag: risk

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Sana intends to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of shares of its common stock. All of the shares of common stock and pre-funded warrants to be sold in the proposed offering will be sold by Sana. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.

NACCO INDUSTRIES ANNOUNCES SECOND QUARTER 2025 RESULTS

CLEVELAND, Aug. 6, 2025 /PRNewswire/ --  Consolidated Q2 2025 Results: Revenues of $68.2 million increased 30% over Q2 2024Increased other income and lower tax expense partly...

Vital Energy Reports Second-Quarter 2025 Financial and Operating Results

TULSA, OK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Vital Energy, Inc. (NYSE: VTLE) ("Vital Energy" or the "Company") today reported second-quarter 2025 financial and operating results. Supplemental slides have been posted to the Company's website and can be found at www.vitalenergy.com. A conference call is planned for 7:30 a.m. CT, Thursday, August 7, 2025. A webcast will be available through the Company's website.

New Slot Sites 2025: Jackpota Adds New Online Slot Games 

Jackpota has released new slot games, solidifying its position as one of the best online gaming casinos.
Jackpota has released new slot games, solidifying its position as one of the best online gaming casinos.

Occidental Announces Further Progress on Asset Sales and Debt Reduction

HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced it has signed four agreements to divest select Permian Basin assets, generating approximately $950 million in proceeds to be used for debt reduction:

Kulicke & Soffa Reports Third Quarter 2025 Results

SINGAPORE, Aug. 6, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa," "K&S," "our," or the "Company"), today announced financial...

H.I.G. Capital Launches GP Solutions Platform

GP-Led Secondaries Fundraise Targeted for Q1 2026 MIAMI , Aug. 6, 2025  /CNW/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $70 billion of capital under management, is pleased to announce...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

NSC and Safety On The Edge Announce Strategic Co-location in Baltimore

WASHINGTON, Aug. 6, 2025 /PRNewswire/ -- The National Safety Council and Safety On The Edge Global Forum are proud to announce a groundbreaking partnership that...

EnerCom Announces Andrew Rapp, Senior Advisor in the U.S. Department of Energy, as Keynote Speaker on August 18th at EnerCom’s 30th Anniversary Energy Investment...

Qualified Investors and Analysts Can Register at No Cost at  www.enercomdenver.com Deadline to Submit One-on-One Meeting Requests to Presenting Companies is Friday, August 8th  Registration still...

Bloomberg Tax Provision Releases Built-in ASU 2023-09 Rate Reconciliation Report

ARLINGTON, Va., Aug. 6, 2025 /PRNewswire/ -- Bloomberg Tax announced today a significant enhancement to its Provision software with the introduction of a new...

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

Presentations showcased at World Transplant Congress in San Francisco demonstrate HOPE reduces the cost of liver transplantation by shortening the index hospitalization and decreasing...

Immix Biopharma Announces Other Serious Diseases Strategy

– Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) –

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRisk